CCN2 scores did not correlate with age, sex, type of driver mutation, blood values (hemoglobin, leucocytes, platelets, LDH) or the occurrence of thrombovascular events in MPN patients. This evidence concerns the gene CCN2 and myeloproliferative disorder.